3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
16
Myelodysplastic Syndromes
12
Multiple Myeloma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Hematologic Neoplasms
6
Neuroblastoma
5
Hodgkin Disease
5
Retinoblastoma
4
Lymphoma, Non-Hodgkin
4
Graft vs Host Disease
4
Anemia, Refractory, with Excess of Blasts
4
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Recurrence
2
Primary Myelofibrosis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Leukemia
2
Ganglioneuroblastoma
2
Anemia, Aplastic
2
beta-Thalassemia
1
Venentoclax
1
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Interventions
Gemcitabine
54
130-nm albumin-bound paclitaxel
29
Magnetic Resonance Spectroscopy
21
Taxes
18
Fluorouracil
18
Specimen Handling
17
Oxaliplatin
17
Leucovorin
17
Drug Therapy
17
Albumin-Bound Paclitaxel
17
Irinotecan
14
pembrolizumab
13
Cyclophosphamide
11
Blood Specimen Collection
11
Biopsy
11
fludarabine
10
Radiosurgery
9
irinotecan sucrosofate
8
folfirinox
6
Magnetic Resonance Imaging
6
Cetuximab
6
Bevacizumab
6
dehydroftorafur
5
Surveys and Questionnaires
5
Nivolumab
5
Endoscopic Ultrasound-Guided Fine Needle Aspiration
5
sintilimab
4
olaparib
4
balstilimab
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pancreatic Neoplasms
×
Melphalan
×
Clear all
NCT04150042
2026-01-29
SHARON
General Oncology, Inc.
Phase 1
Recruiting
24 enrolled